Blue Lake Biotechnology, Inc.
PrivateLast Round
Grant
Jun 13, 2024
Total Funding Raised
$46M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Blue Lake Biotechnology, Inc. operates in Healthcare & Life Sciences and is based in Athens, Georgia. Its latest recorded funding round was a Grant round in June 2024.
Blue Lake Biotechnology, Inc. is a biotechnology company that develops intranasal vaccines using a proprietary parainfluenza virus 5 (PIV5) vector platform to prevent serious infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blue Lake Biotechnology, Inc. Comparables
Compare Blue Lake Biotechnology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyanVac LLC | 96% | |
| Codagenix | 89% | |
| BlueWillow Biologics | 84% |
For institutional investors. Book with your work email.
Blue Lake Biotechnology, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Blue Lake Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 103% MoM, reaching 1.8K.
- Jun 1, 2026
Grew 20% QoQ, from 15 to 18 employees.
For institutional investors. Book with your work email.
Blue Lake Biotechnology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Blue Lake Biotechnology, Inc.'s valuation, stock price, and market status.
Is Blue Lake Biotechnology, Inc. a public or private company?
Blue Lake Biotechnology, Inc. is a private company.
What is the current stock price of Blue Lake Biotechnology, Inc.?
Blue Lake Biotechnology, Inc. is a private company, so its shares have no public market price. Caplight tracks Blue Lake Biotechnology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Blue Lake Biotechnology, Inc. worth (valuation)?
Valuation information for Blue Lake Biotechnology, Inc. is not publicly available.
Can I buy Blue Lake Biotechnology, Inc. stock?
Blue Lake Biotechnology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Blue Lake Biotechnology, Inc.'s last funding round?
Blue Lake Biotechnology, Inc.'s most recent funding round was Grant on June 13, 2024.
Who are the main investors in Blue Lake Biotechnology, Inc.?
Key investors in Blue Lake Biotechnology, Inc. include U.S. Department of Health and Human Services, Public Health Emergency Medical Countermeasures Enterprise.
Will Blue Lake Biotechnology, Inc. IPO soon?
No public IPO plans have been announced for Blue Lake Biotechnology, Inc..
How can I track Blue Lake Biotechnology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Blue Lake Biotechnology, Inc.'s shares on secondary markets.